Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc. | Financial_Report.xls |
| EX-32.1 - EX-32.1 - Q Therapeutics, Inc. | d900336dex321.htm |
| EX-31.2 - EX-31.2 - Q Therapeutics, Inc. | d900336dex312.htm |
| EX-31.1 - EX-31.1 - Q Therapeutics, Inc. | d900336dex311.htm |
| EX-32.2 - EX-32.2 - Q Therapeutics, Inc. | d900336dex322.htm |
| EX-10.4.1 - EX-10.4.1 - Q Therapeutics, Inc. | d900336dex1041.htm |
| 10-K - 10-K - Q Therapeutics, Inc. | d900336d10k.htm |
| EX-21.1 - EX-21.1 - Q Therapeutics, Inc. | d900336dex211.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Q Therapeutics, Inc.
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-184141) pertaining to the Amended and Restated Q Therapeutics 2011 Equity Incentive Compensation Plan and the Amended and Restated Q Therapeutics 2002 Stock Incentive Plan”, of our report dated March 31, 2015, with respect to the consolidated financial statements of Q Therapeutics, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2014.
/s/ Tanner LLC
March 31, 2015
Salt Lake City, Utah